News
Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
News
Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
Read time:
Want a FREE PDF version of This News Story?
Complete the form below and we will email you a PDF version of "Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration"
First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?
Thrombotargets Corp and Instituto Biomar have announced the signature of a drug discovery collaboration agreement.
Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.
Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.
Advertisement
